Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4534_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
6 Innate andAdaptive Immunity oftheRespiratory System
83
during RSV and inuenza infection. But AMs may not always be useful. In human metapneumovirus infection, AMs mediate an early entrance into the lung, and facil­itate replication as well as the secretion of inammatory factors, promoting lung pathology [16]. Furthermore, AMs are potential reservoirs of HIV-1, which disrupt the phagocytosis function of AMs, making patients prone to respiratory infections. As innate immune cells, AM is also responsible for maintaining a suppressed envi­ronment through the production of TGF-B that drives Treg development [17].
Dendritic cells (specialized antigen-presenting cells) present in the respiratory tract offer inhaled pathogens as the processed peptides to antigen-specic T cells before they migrate to the lymph nodes. DCs represent the intermediary between innate and adaptive immunity systems. They serve an important role in virus infec­tions such as H1N1 or RSV by inducing the secretion of type I interferon and acti­vating the adaptive immune mechanisms.
Neutrophils are involved in the early response of innate immunity. They are the predominant leukocytes in the circulation. They have both direct and indirect anti­microbial efcacies in innate immunity. They kill infectious agents directly using phagocytosis, by forming neutrophil extracellular traps (NETs), or by the activation of other innate immune cells like macrophages. Neutrophils are the early and more plentiful immune cells entering the respiratory system in acute inammation. Neutrophils are involved in the removal of pathogens and cellular material from the airways mediated by phagocytosis, degranulation, and the release of NETs [1]. The formation of NETs, called NETosis, is a form of programmed death of neutrophils distinct from apoptotis and necrosis. NETosis, when deregulated, has been shown to exacerbate inammation leading to microvascular thrombosis, and contributes to viral acute respiratory distress syndrome (ARDS) [18]. In human A/H1N1 and A/ H7N9 inuenza infection, NETs have been shown to increase the alveolar permea­bility and lead to disease aggravation. Elevated biomarkers of NETs have been asso­ciated with both severe inuenza and, more recently, COVID-19 [19, 20].
Innate lymphoid cells (ILCs) are self-regenerating, tissue-resident innate cells present in the airways. ILCs share many features with traditional CD4 and CD8 T cells. Different from lymphocytes, ILCs do not have expression of antigen-specic cell receptors (TCRs), and are responsive to cytokine production. ILCs are classi­ed into three groups (ILC1s, ILC2s, ILC3s) that are roughly similar to Th1, Th2, and Th17/22 cells. ILC1 cells are essential for immune surveillance, and respond against airborne pathogens in an early manner, primarily through the production of IFN-γ and TNFɑ. ILC2s mimic Th2 lymphocytes, and express type 2 cytokines including IL-4, IL-5, and IL-13in response to IL-25, IL-33, and thymic stromal lymphopoietin (TSLP). ILC2s are signicant cells in allergic reactions, asthma, and clearance of helminths from the lung. ILC3s are mimic to Th17/Th22 lymphocytes. They are the largest group of ILCs found in the human lung, but the literature emphasizing the task of the ILC3s is quite few. ILC3s mainly produce IL-22in the lung, and they are essential for tissue regeneration after viral infection. IL-17 expression of ILC3s may play a role in defending against extra-cellular bacteria and fungi. These cells have transcriptional plasticity and may adopt niche-specic func­tional roles according to environmental cytokines [1, 4].
84
E. Hazar et al.
γδ T cells are a subset of T lymphocytes that possess innate immune cell charac­teristics and are thought to serve the connection between innate and adaptive immune systems. Early in development, they translocate to mucosal surfaces, and they are assessed as tissue-resident T cells. γδ T cells are central to the elimination of numerous infections. During Pneumocystis carinii infection, γδ T cells stimulate host immunity through interactions with CD8+ T cells and local IFN-γ production. In tuberculosis infection, they release IFN-γ and trigger macrophages to generate nitric oxide. In other bacterial infections, γδT cells are essential for TNF-α and IFN-γ generation and bacterial clearance, establishing those cells as a signicant element of the innate immune system [4].

6.3 Adaptive Immunity

The innate immune response is the rst defense mechanism against pathogens that cause infection. In addition to the innate immune system, cells of the adaptive immune system also play a role in the elimination of pathogens in the respiratory system. The adaptive immune response comes into play later than the innate immune response but could not have a protective effect without the support of the local innate immune system and stromal cells [21]. Whereas innate immune responses are triggered within minutes following the detection of PAMPs, the adaptive immune response is highly antigen-specic and develops over several days to sev­eral weeks [1].
The respiratory adaptive immune system consists of cellular and humoral immu­nity with soluble mediators such as cytokines, adaptive immune system’s cells migrate into tissue when activated by infection or tissue damage [22, 23]. This sys­tem involves T cells, including CD8+T cells, which are mainly in charge of directly killing infected cells, and CD4+T cells (or Th1), which mediate additional stimula­tion of adaptive cytolytic immunity or B-cell-mediated responses (Th2), and B cells, which are involved in the production of antibodies to neutralize pathogens or stimulate additional functional responses in innate cells [1, 22].
6.3.1 Cells ofCellular Immunity: T Cells andTheir Subsets
T cells, which are important cells of the adaptive immune system, interact with other immune system cells and perform many tasks such as the production of immu­nomodulatory cytokines and killing antigen-specic infected cells. Thus plays an important role in the control of infections in the respiratory system. T cells working in the respiratory system can generally be divided into two groups: T cells that respond to acute infection and memory T cells (TMC) that form after infection and maintain the immune response for a long time [1].
Cytotoxic CD8+ T cells (CTLs), which produce an acute response against the infectious agent, are cells that secrete anti-inammatory cytokines such as IL-10, and they recognize the class I MHC bound peptide presented by antigen-presenting
6 Innate andAdaptive Immunity oftheRespiratory System
85
cells (APCs) such as dendritic cells [24]. These cells kill the infected cells through the secretion of cytolytic enzymes. Although CTLs play a critical role in the response to the infectious agent, dysregulated responses in these cells can cause severe lung damage [23, 25, 26].
Other T cells in the adaptive immune system are CD4+ helper T cells, which dif­ferentiate into various subsets including Th1, Th2, Th17, follicular T (Tfh), and regu­latory T (Treg) under the inuence of cytokines in the microenvironment [1]. In addition to activating macrophages, Th1 cells are involved in the response to intracel­lular lung infection through IFN-γ and IL-2 cytokines. Th2 cells, which secrete IL-4, IL-5, and IL-13 cytokines, are involved in allergic inammation and in the response to parasitic infections [27]. Th17 cells not only produce cytokines involved in the innate immune response in the lungs but also support the integrity of the epithelium by stimulating the proliferation of epithelial cells. IL-17A and IL-22 cytokines, which are produced by CD4+T cells, are very important in homeostasis and tissue repair. As a part of mucosal immunity, they are associated with innate immune defense [4].
CD4+FoxP3+ Tregs, which are formed in the later stages of pulmonary inam­mation, are cells that are important in maintaining airway tolerance through IL-10 and TGF-β production. In addition to immune tolerance, Treg cells stimulate tissue repair, induce differentiation of type I and type II pneumocytes, and inhibit brocyte aggregation and proliferation [28]. T follicular helper (Tfh) cells are cells that help develop B-cell-mediated humoral responses to infection.
In the late phase of acute infections/inammation, both CD4+ and CD8+ mem­ory T cells (TMC) develop in the respiratory system. TMCs are present in the upper and lower respiratory tracts and play an important role in the prevention of viral infections. TMCs are cells that respond rapidly to infections and quickly perform their effector functions when they encounter an infectious agent. In addition, TMCs not only eliminate the infectious agent but also maintain tissue integrity through the cytokines and chemokines they secrete [29]. These T cells are long-lived, and express CD69+CD103+ following re-infection or vaccination, then called T resi­dent helper (TRH) cells. TRH (TRH) cells are not circulating cells, and remain stable in the mucosal site throughout their lifetime. These cells, recently identied follow­ing inuenza infection in mice, are functionally similar to Tfh and TCM cells [30]. These cells are both phenotypically and functionally distinct from effector memory T (TEM) cells and reside in the respiratory mucosa throughout life to function by increasing the expression of integrins and selectins as needed [1, 31].
6.3.2 Cells ofHumoral Immunity: B Cells andB Cell Subsets
Similar to T cells, B cells migrate to the lymph node after encountering antigens and settle in the T/B cell region of the lymph node. In this region, some of the B cells differentiate into short-lived plasma cells, while others move toward the germinal center where maturation occurs. In the germinal center, B cells expand clonally and differentiate into long-lived plasma cells and/or memory B cells (BMCs) with the help of Tfh cells [32].
86
E. Hazar et al.
In the early stages of infection, short-lived plasma cells form, and cause the release of low-afnity IgG and IgA at the site of infection. On the other hand, in the later stages of infection, plasma cells secreting high-afnity immunoglobulin are formed. IgA is more commonly found in the respiratory mucosa, and both IgA and IgG have been shown to be effective against infections in the respiratory tract [33]. Due to mechanisms by which a tissue-specic cell is directed to a specic tissue or organ, antigen-specic IgA+ B cells differentiate into monomeric IgA (mIgA)-pro­ducing plasma cells before differentiating into polymeric IgA (pIgA)-producing plasma cells to migrate toward the effector site [24]. pIgA forms a complex with the polymeric Ig receptor (pIgR) expressed by epithelial cells. This results in the forma­tion of secretory IgA [34]. The synthesis of IgA antibodies and the production of tissue-resident memory T cells (TMC) are important features of adaptive immune responses. Secreted mucosal IgA prevents antigens and pathogens from invading the mucosa by various mechanisms [35]. During the recovery phase after acute pulmonary inammation, B cells can differentiate into memory cells or like T cells, can reside in the airways as tissue-resident memory B (BRM) [34, 36]. In the light of current information, BRM cells, together with other cells of the respiratory tract, are thought to be important mediators of protective humoral responses against pul­monary infections and airway immune surveillance.
As a result, the respiratory system is a highly complex system for human health, interacting with the external environment and playing a critical role as the rst-line defense against lung injury caused by inhaled pathogens and toxins. There is enor­mous complexity among cellular and humoral immune responses in the airways following infection and vaccination. Innate immune cells in the lung respond to non-antigen-specic signals from their environment, enabling them to mobilize quickly in the presence of a threat. Adaptive immunity, which develops following the innate immune response, is highly antigen-specic and it is important in long­lasting immunity.
Conict of Interest None.
There is no conict of interest of any authors.

References

1. Mettelman RC, Allen EK, Thomas PG.Mucosal immune responses to infection and vaccina­tion in the respiratory tract. Immunity. 2022;55(5):749–80.
2. Gopallawa I, Dehinwal R, Bhatia V, etal. A four-part guide to lung immunology: invasion, inammation, immunity, and intervention. Front Immunol. 2023;14:1119564. https://doi.
org/10.3389/mmu.2023.1119564.
3. Parker D, Prince A.Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol. 2011;45(2):189–201. https://doi.org/10.1165/rcmb.2011- 0011RT.
4. Galeas-Pena M, McLaughlin N, Pociask D. The role of the innate immune system on pul­monary infections. Biol Chem. 2019;400(4):443–56. https://doi.org/10.1515/hsz- 2018- 0304.
5. Short KR, Kasper J, van der Aa S, etal. Inuenza virus damages the alveolar barrier by dis­rupting epithelial cell tight junctions. Eur Respir J. 2016;47(3):954–66. https://doi.org/10.118
3/13993003.01282- 2015.
6 Innate andAdaptive Immunity oftheRespiratory System
6. Kast JI, McFarlane AJ, Głobińska A, etal. Respiratory syncytial virus infection inuences tight junction integrity. Clin Exp Immunol. 2017;190(3):351–9. https://doi.org/10.1111/cei.13042.
7. Higgins G, Fustero Torre C, Tyrrell J, etal. Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic brosis bronchial epithelial cells by Pseudomonas aerugi­nosa. Am J Physiol Lung Cell Mol Physiol. 2016;310(11):L1053–61. https://doi.org/10.1152/
ajplung.00368.2015.
8. Wittekindt OH. Tight junctions in pulmonary epithelia during lung inammation. Pugers Arch. 2017;469(1):135–47. https://doi.org/10.1007/s00424- 016- 1917- 3.
9. Kim KC. Role of epithelial mucins during airway infection. Pulm Pharmacol Ther. 2012;25(6):415–9. https://doi.org/10.1016/j.pupt.2011.12.003.
10. Zhang H, He F, Li P, etal. The role of innate immunity in pulmonary infections. Biomed Res Int. 2021;2021:6646071. https://doi.org/10.1155/2021/6646071.
11. Alvarez-Simon D, Ait Yahia S, de Nadai P, etal. NOD-like receptors in asthma. Front Immunol. 2022;13:928886. https://doi.org/10.3389/mmu.2022.928886.
12. Choi SM, McAleer JP, Zheng M, et al. Innate Stat3-mediated induction of the antimicro­bial protein Reg3γ is required for host defense against MRSA pneumonia. J Exp Med. 2013;210:551–61.
13. Hillaire MLB, van Eijk M, Vogelzang-van Trierum SE, etal. Recombinant porcine surfactant proteinD inhibits inuenza A virus replication exvivo. Virus Res. 2014;181:22–6. https://doi.
org/10.1016/j.virusres.2013.12.032.
14. Jin H, Ciechanowicz AK, Kaplan AR, et al. Surfactant protein C dampens inammation by decreasing JAK/STAT activation during lung repair. Am J Physiol Cell Mol Physiol. 2018;314:L882–92. https://doi.org/10.1152/ajplung.00418.2017.
15. Sun S, Zhao G, Liu C, Wu X, etal. Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian inuenza H5N1 virus infection. Am J Respir Cell Mol Biol. 2013;49:221–30. https://doi.org/10.1165/rcmb.2012- 0428OC.
16. Kolli D, Gupta MR, Sbrana E, et al. Alveolar macrophages contribute to the pathogen­esis of human metapneumovirus infection while protecting against respiratory syncytial virus infection. Am J Respir Cell Mol Biol. 2014;51(4):502–15. https://doi.org/10.1165/
rcmb.2013- 0414OC.
17. Cribbs SK, Lennox J, Caliendo AM, et al. Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages. AIDS Res Hum Retroviruses. 2015;31(1):64–70. https://doi.org/10.1089/AID.2014.0133.
18. Yang H, Biermann MH, Brauner JM, et al. New insights into neutrophil extracellular traps: mechanisms of formation and role in inammation. Front Immunol. 2016;7:302. https://doi.
org/10.3389/mmu.2016.00302.
19. Zhu L, Liu L, Zhang Y, etal. High level of neutrophil extracellular traps correlates with poor prognosis of severe inuenza A infection. J Infect Dis. 2018;217(3):428–37. https://doi.
org/10.1093/infdis/jix475.
20. Zuo Y, Yalavarthi S, Shi H, etal. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999. https://doi.org/10.1172/jci.insight.138999.
21. Iwanaga N, Devarajan P, Shenoy AT.Editorial: Adaptive immunity to respiratory pathogens. Front Immunol. 2023;14:1174178. https://doi.org/10.3389/mmu.2023.1174178.
22. He X, Chen X, Wang H, et al. Recent advances in respiratory immunization: a focus on COVID-19 vaccines. J Control Release. 2023;355:655–74. https://doi.org/10.1016/j.
jconrel.2023.02.011.
23. Stambas J, Lu C, Tripp RA.Innate and adaptive immune responses in respiratory virus infec­tion: implications for the clinic. Expert Rev Respir Med. 2020;14(11):1141–7. https://doi.
org/10.1080/17476348.2020.1807945.
24. Sato S, Kiyono H. The mucosal immune system of the respiratory tract. Curr Opin Virol. 2012;2(3):225–32. https://doi.org/10.1016/j.coviro.2012.03.009.
25. Schmidt ME, Varga SM. The CD8 T cell response to respiratory virus infections. Front Immunol. 2018;9:678. https://doi.org/10.3389/mmu.2018.00678.
87
88
26. Guo K, Yombo DJK, Xu J, etal. The chemokine receptor CXCR3 promotes CD8+ T cell­dependent lung pathology during inuenza pathogenesis. Preprint at bioRxiv. 2022; https://
doi.org/10.1101/2022.02.14.480379.
27. Schattgen SA, Thomas PG.TRH cells, helpers making an impact in their local community. Sci Immunol. 2021;6(55):eabf2886. https://doi.org/10.1126/sciimmunol.abf2886.
28. D’Alessio FR, Tsushima K, Aggarwal NR, etal. CD4+CD25+Foxp3+ Tregs resolve experi­mental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 2009;119(10):2898–913. https://doi.org/10.1172/JCI36498.
29. Rakhra K, Abraham W, Wang C, etal. Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells. Sci Immunol. 2021;6(57):eabd8003.
https://doi.org/10.1126/sciimmunol.abd8003.
30. Swarnalekha N, Schreiner D, Litzler LC, et al. T resident helper cells promote humoral responses in the lung. Sci Immunol. 2021;6(55):eabb6808. https://doi.org/10.1126/sciimmu-
nol.abb6808.
31. Purwar R, Campbell J, Murphy G, etal. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specicity. PLoS One. 2011;6(1):e16245. https://
doi.org/10.1371/journal.pone.0016245.
32. Pereira JP, Kelly LM, Cyster JG.Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. Int Immunol. 2010;22(6):413–9. https://doi.org/10.1093/
intimm/dxq047.
33. Barker KA, Etesami NS, Shenoy AT, etal. Lung-resident memory B cells protect against bac­terial pneumonia. J Clin Invest. 2021;131(11):e141810. https://doi.org/10.1172/JCI141810.
34. Johansen FE, Braathen R, Brandtzaeg P.Role of J chain in secretory immunoglobulin forma­tion. Scand J Immunol. 2000;52(3):240–8. https://doi.org/10.1046/j.1365- 3083.2000.00790.
35. Strugnell RA, Wijburg OL. The role of secretory antibodies in infection immunity. Nat Rev Microbiol. 2010;8(9):656–67. https://doi.org/10.1038/nrmicro2384.
36. Onodera T, Takahashi Y, Yokoi Y, etal. Memory B cells in the lung participate in protective humoral immune responses to pulmonary inuenza virus reinfection. Proc Natl Acad Sci U S A. 2012;109(7):2485–90. https://doi.org/10.1073/pnas.1115369109.
E. Hazar et al.
Immune Responses toRespiratory Infections
EzgiTopyildiz, FrancescoCinetto, andGuzideAksu

7.1 Introduction

The respiratory system is a complex system representing both a physical and immu­nological barrier between the external environment and the blood and tissues. It provides gas exchange and oxygenation of the blood and is a crucial component of the body’s defenses against various pathogens that can cause infections. In response to harmful microorganisms entering the respiratory tract, such as viruses, bacteria, fungi, and protozoa, a complex and multifaceted response occurs. Respiratory cells and innate immune cells initiate the clearing and resolution of infection, followed by the intervention of adaptive immune cells. A range of cellular and molecular mechanisms are involved in this immune response, which is responsible for identi­fying, neutralizing, and eliminating invading pathogens [1]. Recurrent and severe respiratory tract infections, particularly if caused by atypical pathogens, are indeed listed among the key warning signs that should raise the suspicion of an Inborn Error of Immunity (IEI), both in pediatric and adult patients [2].
Acute respiratory tract infections (ARTIs) are the leading cause of symptomatic illness worldwide and are frequently caused by viruses, although bacteria and fungi can also cause ARTIs [3]. Both innate and adaptive defense systems are involved in antimicrobial immunity [4].
7
E. Topyildiz Department of Pediatric Allergy and Immunology, Acıbadem Healthcare Group, Ataşehir Hospital, Istanbul, Turkey
F. Cinetto Rare Diseases Referral Center, Internal Medicine 1, Department of Medicine (DIMED), AULSS2 Marca Trevigiana, Ca’ Foncello Hospital, University of Padova, Podova, Italy
G. Aksu (*) Department of Pediatric Immunology, Ege University Faculty of Medicine, Izmir, Turkey
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2024 H. Yüksel et al. (eds.), Pediatric Airway Diseases, Comprehensive ENT,
https://doi.org/10.1007/978-3-031-74853-0_7
89
90
E. Topyildiz et al.
Respiratory epithelial cells form the rst physical barrier to infection and express Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), such as retinoic acid-inducible gene I (RIG I), which recognize viral components and can produce antiviral IFNs in response [47]. Mucus provides a physical barrier to pre­vent microorganisms from being captured and removed by mucociliary clearance. Additionally, mucins serve as scaffolds for antimicrobial proteins. The innate defense system includes neutrophils, eosinophils, basophils, monocytes, macro­phages, dendritic cells (DCs), natural killer (NK), and natural killer T (NKT) cells.
Innate immune system cells use PRRs to identify viral replication in infected host cells, which triggers the early response to viral airway infections. Pattern rec­ognition receptors recognize components of the bacterial cell wall (lipopolysaccha­rides and peptidoglycans), structures of potential pathogens, and intracellular components of pathogens, including DNA and RNA.
Toll-like receptors are among the most widely studied and well-known PRRs. In particular, TLR7 and TLR8 are effective against viruses with single-stranded RNA, such as inuenza virus, SARS-CoV-2, rhinovirus, and respiratory syncytial virus (RSV). In human cells, they detect single-stranded RNA, which is absent during normal metabolic processes. When TLR7 and TLR8 recognize pathogenic struc­tures, they initiate the production of antiviral type I and type III interferons (IFNs), resulting in a direct inhibitory effect on viral replication. In addition, these interfer­ons (α, β, and λ) promote the activation of nearby cells’ antiviral defenses [4, 8].
The bacteria that can cross the mucus layer reach the epithelial surface, where they are rapidly detected by numerous PRRs like those in viruses. Lipoteichoic acids of pneumococci and S. aureus are recognized by TLR-2, whereas the lipopro­teins and lipopolysaccharides of H. inuenzae can be recognized by TLR-2 and TLR-4, respectively [9]. In the context of pneumococci immunity, lack of molecules downstream of the IL-1 receptor (IRAK-4, MyD88, etc.) or the absence of a func­tional spleen is also associated with increased rates of invasive disease. As with most of these diseases, the period of greatest susceptibility to invasive pneumococ­cal disease is early childhood [10]. Circulating monocytes respond to virus-induced inammatory signals and contribute to antiviral immunity by inltrating infected tissues [11]. They can, however, also cause damage to the host tissues by causing local inammation. Their activation results in the production of IFN-I, which is a signal that further activates NK cells, other monocytes, and CD8+ T cells [11]. In accordance with this, mice lacking C–C chemokine receptor type 2 (CCR2) have displayed impaired monocyte recruitment, leading to a decrease in the priming of CD8+ T cells directed against the inuenza virus and a delay in the clearance of the virus [1113].
Dendritic cells (DCs) have a crucial role in antiviral immunity by acting as a link between the innate and adaptive immune systems. There are three distinct types of DCs involved in this interaction: conventional type 1 DCs (cDC1), conventional type 2 DCs (cDC2), and plasmacytoid DCs (pDCs) [11]. Dendritic cells lining the upper respiratory tract mature into antigen-presenting cells when activated. The activation of DCs increases levels of class I and class II key tissue compatibility complex molecules and induces a wide variety of costimulatory and adhesion
7 Immune Responses toRespiratory Infections
91
molecules and inammatory cytokines essential for T-cell responses. Unlike cDCs, which perform their functions primarily through T cells, pDCs produce high levels of type I IFNs. These IFNs play an essential role in antiviral immunity, although their importance in respiratory viral infections may vary [11]. For instance, although pDCs are the main source of IFN-I in RSV infection, they are also needed to pro­duce IFN-I and generate antiviral immunity following inuenza infection [11,
1417]. Moreover, the importance of type I IFNs has been recently highlighted in
response to SARS-COV-2 infections; indeed, inborn errors of, and auto-antibodies against type I IFNs underlie life-threatening COVID-19 pneumonia [18].
Natural killer cells are members of the innate lymphoid cells (ILCs) family. Their function includes the production of effector cytokines and the destruction of infected cells, which are essential for the antiviral response [11].
The depletion and dysfunction of NK cells, which are crucial to the clearance of viral infections, increase the risk of respiratory viral infections. Type 1 ILCs, which contribute to limiting viral infections, are innate counterparts of IFN-γ-producing T helper 1 (Th1) cells [11, 19, 20]. In addition, certain components of the innate immune system target respiratory pathogens [4]. For example, NKT cells have receptors that can recognize lipids when they are presented on major tissue compat­ibility complex (MHC)-like molecules such as CD1c on innate immune cells. iNKT cells may inhibit the immunosuppressive activity of myeloid suppressor cells during inuenza A infection and shorten the duration of the infection [4, 2123].
Unlike viruses, bacteria are attacked by immune proteins known as complement proteins when they enter the circulation. Complement proteins are involved in kill­ing bacteria through three pathways: the classical complement pathway, the alterna­tive complement pathway, and the lectin pathway. The rst step of the classical complement pathway requires antibodies to bind to the surface of the target bacte­ria. The antibodies are then targeted by a specic complement protein complex. Once bound, it initiates the disassembly and remodeling of complement complexes that produce opsonins that tag bacteria for destruction. At the end of this pathway, the membrane attack complex (MAC) is formed. MAC can localize to Gram­negative bacteria cell membranes, but not to Gram-positive bacteria cell mem­branes. This process produces pores that facilitate the entry of membrane-damaging molecules such as lysozyme into bacteria, making them susceptible to osmotic lysis. The alternative complement pathway does not require antibodies. In this path­way, complement proteins of a complex known as C3 bind directly to bacteria and activate downstream components of the complement cascade. This results in the formation of MAC, which causes lysis of the bacteria. During the lectin pathway, mannan-binding lectin (MBL) attaches to proteins containing mannose residues found in some bacterial species [24]. The importance of complement in defense against respiratory infections is recapitulated by the clinical features of patients with primary complement deciencies [25].
Even though innate immune responses are responsible for the initial control of microbial spread, adaptive immunity must be active to ensure the complete clear­ance of the pathogen. Adaptive immunity encompasses both humoral responses mediated by B cells and cellular immunological responses mediated by T cells.
92
E. Topyildiz et al.
After intimate contact with innate immune cells, humoral and cellular immunity work together to stimulate adaptive responses. In contrast to innate immunity, which responds quickly to respiratory infections without having any antigen specicity, adaptive immune responses take time to develop antigen specicity while also forming long-term memory [26].
Pathogenic peptide fragments are collected by macrophages, monocytes, and DCs, which are then presented to T cells that recognize MHC molecules or the human leukocyte antigen (HLA)—the MHC peptide complex [4]. In this way, T cells are activated and antigen-specic B cells are instructed. As soon as the naive B cells are activated, they produce antibodies or migrate to the infection site with T cells to destroy the infected cells (Fig. 7.1). When naive CD4+ T lymphocytes are activated, they differentiate into specic types of helper T lymphocytes (e.g., Th1, Th2, or Th17) and expand clonally according to the cytokine environment during activation [27]. For example, in inuenza infection, CD4+ T cells generally pro­mote the differentiation and activation of antibody-producing B cells while also
Fig. 7.1 Mechanism of immune response